These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22633783)

  • 21. The role of adiponectin multimers in anorexia nervosa.
    Amitani H; Asakawa A; Ogiso K; Nakahara T; Ushikai M; Haruta I; Koyama K; Amitani M; Cheng KC; Inui A
    Nutrition; 2013 Jan; 29(1):203-6. PubMed ID: 23237649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Zavos C; Tsiaousi E
    Diabetes Obes Metab; 2010 May; 12(5):365-83. PubMed ID: 20415685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin.
    Graessler J; Gruber M; Radke RB; Kopprasch S; Schwarz PE; Kamke W; Bornstein SR; Fischer S
    Gerontology; 2011; 57(4):316-26. PubMed ID: 20551622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes.
    Li Y; Wang P; Zhuang Y; Lin H; Li Y; Liu L; Meng Q; Cui T; Liu J; Li Z
    FEBS Lett; 2011 Jun; 585(12):1735-40. PubMed ID: 21536037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hyperinsulinaemia and hyperlipidaemia modify circulating adiponectin and its oligomers.
    Bobbert T; Weicht J; Mai K; Möhlig M; Pfeiffer AF; Spranger J
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):507-11. PubMed ID: 19751297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiponectin oligomers and ectopic fat in liver and skeletal muscle in humans.
    Kantartzis K; Staiger H; Machann J; Schick F; Claussen CD; Machicao F; Fritsche A; Häring HU; Stefan N
    Obesity (Silver Spring); 2009 Feb; 17(2):390-2. PubMed ID: 19169222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
    Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
    Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue-specific effect of dietary cysteamine on expression of adiponectin receptors in rats.
    Xu J; Shao W; Chi H; Tan Y; Zhao R
    J Agric Food Chem; 2007 Sep; 55(19):7968-73. PubMed ID: 17696487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
    Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of adiponectin gene functional polymorphisms (-11377C/G and +45T/G) with nonalcoholic fatty liver disease.
    Gupta AC; Misra R; Sakhuja P; Singh Y; Basir SF; Sarin SK
    Gene; 2012 Mar; 496(1):63-7. PubMed ID: 22269154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term treatment of cystinosis in children with twice-daily cysteamine.
    Dohil R; Gangoiti JA; Cabrera BL; Fidler M; Schneider JA; Barshop BA
    J Pediatr; 2010 May; 156(5):823-7. PubMed ID: 20138296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ; Sirlin CB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The proportion and metabolic effects of adiponectin multimeric isoforms in patients with chronic kidney disease on maintenance hemodialysis.
    Abe Y; Eto S; Matsumae T; Ogahara S; Murata T; Watanabe M; Nakashima H; Saito T
    Ren Fail; 2010; 32(7):849-54. PubMed ID: 20662699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
    Gómez-Zorita S; Fernández-Quintela A; Macarulla MT; Aguirre L; Hijona E; Bujanda L; Milagro F; Martínez JA; Portillo MP
    Br J Nutr; 2012 Jan; 107(2):202-10. PubMed ID: 21733326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
    Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
    Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease.
    Guha S; Konkwo C; Lavorato M; Mathew ND; Peng M; Ostrovsky J; Kwon YJ; Polyak E; Lightfoot R; Seiler C; Xiao R; Bennett M; Zhang Z; Nakamaru-Ogiso E; Falk MJ
    Hum Mol Genet; 2019 Jun; 28(11):1837-1852. PubMed ID: 30668749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between adiponectin multimer levels and subtypes of cerebral infarction.
    Tagawa N; Fujinami A; Natsume S; Mizuno S; Kato I
    PLoS One; 2022; 17(1):e0262542. PubMed ID: 35085298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cysteamine: an old drug with new potential.
    Besouw M; Masereeuw R; van den Heuvel L; Levtchenko E
    Drug Discov Today; 2013 Aug; 18(15-16):785-92. PubMed ID: 23416144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.